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Summary 
In  polymyositis  (PM),  CD8 +  T  cell receptor  (TCR)  all3 + cells  invade  and  destroy major 
histocompatibility complex class I-positive muscle fibers. We combined polymerase chain reaction 
(PCR)  and double-fluorescence immunocytochemistry  to  analyze the  T  cell  receptor  (TCR) 
repertoire expressed in muscle of PM patients.  In patient  1, inverse PCR revealed  a preferential 
usage of TCR Vot33.1, V313.1, and V35.1.  Six of six TCR Vot33.1 § clones and five of seven 
V/313.1 + clones had identical nucleotide sequences. In contrast,  the VB5.1 + TCRs were more 
heterogeneous. Similar results were obtained with an independent PCR method using primers 
specific  for  TCR  Vot33,  V/313,  or  VBS.  No  TCR  sequences  could  be  amplified  from 
noninflammatory control muscle. Furthermore, none of the TCR sequences found in PM muscle 
could  be  detected  in  blood  from  the  same  patient  or  from  a  normal  control  subject. 
Immunohistochemistry  confirmed that V135.1 and Vr  were overrepresented in the muscle 
lesions  of this  patient.  32%  of all  CD8 +  T  cells  were V/313.1 +,  and  16%  were V/35.1 +. 
However, "~60% of the CD8 § T cells that invaded muscle fibers were V/313.1 +, whereas 10% 
were V/35.1 +. In patient 2, 50% of the T cells were V/35.1+, and as in patient  1, these T  cells 
were mainly located in interstitial  areas. In patient 3, >75% of the autoinvasive T  cells stained 
with an anti-V~3 mAb. Sequence analysis of 15 PCR clones amplified with a V~3-specific primer 
showed that 9 (60%) sequences were identical.  The results suggest that (a) a strikingly limited 
TCR repertoire is expressed in PM muscle; (b) there is a dissociation between the TCR usage 
of autoinvasive and interstitial  T  ceils;  and (c) the autoinvasive T  cells are clonally expanded. 
p tolymyositis (PM) is presumably an autoimmune disease 
caused by T lymphocytes that surround, invade,  and de- 
stroy HLA class I-expressing muscle fibers (1-3). With few 
exceptions (4, 5), the muscle-infiltrating T lymphocytes are 
CD8 +  c~/3  T  cells.  Attempts  to  identify viral  target  an- 
tigens or related gene sequences in muscle fibers have failed, 
and it is generally considered that the recognized epitope is 
probably a muscle-derived auto-Ag  (1-3,  6). 
The characteristic lesion of PM has several unique features 
that make it an ideal paradigm to study CD8 + T cell-medi- 
ated  immunopathology.  The  target  cells,  muhinucleated 
skeletal  muscle fibers, can be readily distinguished from the 
effector T  cells.  A  subpopulation  of CD8 + T  cells  invade 
muscle fibers.  These "autoinvasive" T  cells are presumably 
enriched in auto-Ag-specific cells  (1-3).  Here we have ap- 
plied immunohistochemistry  and PCR techniques to char- 
acterize  the  TCR repertoire  of inflammatory  cells  in  PM 
muscle. 
Materials and Methods 
Clinical Material.  Muscle biopsy specimens and PBMC were 
obtained from patients with typical PM (1-3). FILA  types are known 
for patient 1 (HLA A2/32, B27/44, Cw2/w3, DR2/w11) and pa- 
tient 2 (A26/32, B8/51, C -/-, DR3/wl0). Control muscle tissue 
was  obtained  during  diagnostic  biopsy  from  a  patient  with 
noninflammatory  myopathy. 
Immunohistology.  10-#m cryostat sections of muscle were used 
for paired immunofluorescence studies with FITC-anti-CD8 (10 
#g/ml; Dianova, Hamburg, Germany) and the following mouse 
anti-TCR mAbs: V/35.1, 5.2, 5.3, 6.7, 8, and 12.1 (diluted  1:10; 
T Cell Sciences, Cambridge, MA); V/32, 3, 13.3, 16, 17, 18, 21.3, 
and 22 (diluted 1:10; Immunotech, MarseiUe, France); V/~7.1, 13.1, 
and 13.2 (undiluted supernatants; kindly provided by Dr. M. Callan, 
Molecular Immunology Group, John Radcliffe Hospital, Oxford, 
UK [V137.1] and Dr. P. Marrack, National Jewish Center for Im- 
munology and Respiratory Medicine, Denver, CO [7]). The TCR- 
specific primary antibodies were immunolocalized with carboxy- 
methylindocyanine (Cy3,  10 #g/ml; Dianova)-labeled goat anti- 
mouse IgG. Isotype-matched IgG at identical concentrations was 
substituted  for primary  antibodies for negative controls. 
RNA Extraction and cDNA Synthesis.  Total  RNA was extracted 
from frozen muscle and freshly isolated PBMC with the guanidin- 
ium thiocyanate method (8). Single-stranded cDNA was synthe- 
sized from 2 #g of total KNA using oligo(dT) and Moloney mu- 
rine leukemia virus-derived  reverse transcriptase (GIBCO/BRL, 
Eggenstein,  Germany). 
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as template. TCR ot and fl chains were amplified with 5'-V gene 
family-specific  primers (Vot15: 5'-GGAATTCCAAGACCAAAG- 
ACTCACTG-Y;  Vot33: 5'-GGAATTCGCAGCTTCTTCAGA- 
GAGAG-3'; Vfl3: 5'-GGAATTCTAGAGAGAAGAAGGAGCGC- 
3'; VflS: 5'-GGAATTCTCCTGGTACCAACAG (GA) CCC-Y; 
Vf113: 5'-GGAATTCCCC (CT) (GA) ATGGCTACAATGTC-Y) 
and 3'-primers for the Cot and Cfl regions (Hcot6: 5'-CAATGG- 
ATCCTTGTCACTGGATTTAGAGTC-Y  or Hcfl2: 5'-GGGTCG- 
AC  GGTGTGGGAGATCTCTGC-  3  '). 
Inverse PCR.  For inverse PCR (9), double-stranded  cDNA was 
generated using RNAse H, Escherichia coli DNA polymerase  I, and 
E. coli DNA ligase, followed by incubation with T4 DNA poly- 
merase for blunt-end formation. The blunt-ended cDNA was cir- 
cularized with T4 DNA ligase (GIBCO/BRL) and used as tem- 
plate. Two primer pairs, each containing a forward and reverse TCR 
C region sequence, were used to amplify TCR ot chains (HcotilI: 
5'-GGAATTCCTGCTATC~TGTGTGTCTGG-3';  Hcot6: see above) 
and TCR43 chains (HcBilII: 5'-GGAATTCTGTCTGCCACCATC- 
CTCTATGAG-3'; Hcfl2: see above). All primers contained artificial 
EcoRI (5' primers) or BamHI or BgllI (3' primers) restriction sites. 
Each reaction was carried out in a total volume of 50 #1 containing 
1 U  Taq DNA polymerase (Angewandte Gentechnologie Systeme 
GmbH [AGS], Heidelberg, Germany), 200/~M  of each deoxy- 
nucleotide triphosphate,  150 /zM MgCI2, and 50 pmol of each 
primer in buffer supplied by the manufacturer (AGS). The PCR 
was done for 35 cycles with 1 rain denaturation at 94~  1 rain 
annealing at 60~  I rain extension at 72~  and a final extension 
for 10 min at 72~  in a thermal cycler (Perkin-Elmer Cetus Corp., 
Norwalk,  CT). 
Cloning and Sequencing of PCR Products.  PCR products were 
cloned into M13mp18 for sequence analysis.  TCR Vot samples were 
digested with BamFIl and EcoRI and TCR Vfl samples with BgllI 
and EcoRI to cut restriction sites in the oligonucleotide primers. 
DNA fragments were separated by electrophoresis on a 1% low 
melting point agarose gel and fragments of expected size were iso- 
lated by  jet sorb (Genomed, Bad Oeynhausen, Germany). The iso- 
lated DNA fragments were cloned into BamHI- and EcoRI-digested 
M13mp18. After  transfection into  the  E.  coli strain DH5~FIq 
(GIBCO BILL), clones containing TCR V~ or Vfl inserts were 
identified by hybridization with TCR Cc~- or Cfl-specific oligos 
(xHcot: 5'-CACGC,  CAGGGTCAGGGTTCT-3'  or xHcfl3: 5'-GAA- 
CAC (GC) TT (GT) TTCAGGTCCT-Y). Positive  clones were se- 
quenced by using the dideoxy chain termination method (10) with 
the Sequenase kit (U.S. Biochemical Corp., Cleveland, OH). The 
cDNA sequences were screened against Genbank and EMBL  nucleo- 
tide sequence databases. The TCR nomenclature is used according 
to references 9, 11-16. Some V~ and Vfl elements were reclassified: 
Vot29.1 and Vot33.1 were previously  designated  Votw23 and Vot31, 
and members of the Vf113 family  were previously  designated  Vfl12.3 
and Vfl12.4. 
Results and Discussion 
In a first  stage of analysis, we studied the TCR oe and/5 
chain repertoire expressed  in the muscle of patient 1 by in- 
verse PCR. In contrast to TCR "family PCR" inverse PCR 
is independent of V gene-specific primers, allowing the un- 
biased identification of the expressed TCR V gene repertoire, 
including hitherto unknown V  genes (9). 
While no TCR sequences could be amplified from non- 
inflammatory control muscle, 33 Vol and 32 Vfl clones were 
amplified and sequenced from PM muscle. In parallel, 22 Vot 
1864  CD8+  T Cells in Polymyositis 
and 28 Vfl clones were amplified and sequenced  from the 
PBMC of a healthy subject. 
We found 17 different Vot and 17 Vfl segments in muscle. 
Two Vfl elements (Vfl5.1,  7/32 [22%] clones; Vfl13.1, 7/32 
[22%])  and four Vc~ elements (Vot7,  5/33 clones [15%]; 
VotS.1,  4/33  [12%];  Vot15.1,  3/33  [9%];  Vot33.1,  6/33 
[18%])  were clearly enriched. The TCK Vot and Vfl reper- 
toire of PBMC from the healthy donor was broader. VflS.1 
and Vfl13.1 were expressed by 3/28 (10%) and 2/28 (7%) 
of the PBMC clones,  respectively.  No Vot33.1 + clone was 
found in PBMC. All Vot and Vfl sequences amplified from 
PBMC were different (not shown). 
Sequence analysis of the TCR V~3 clones derived from PM 
muscle indicated that there was striking clonal expansion of 
Vfl13.1 + T cells. Five of seven Vfl13.1 + clones had identical 
sequences (Table 1 B). In contrast, the VflS.1 sequences, which 
were expressed as frequently as Vfl13.1, were more heteroge- 
neous (Table 1 B). 
Analysis of the Vot chains expressed in muscle also pro- 
duced evidence  for clonal expansion.  Six  of six Vot33.1 + 
clones, three of three Vod5 + clones, and three of five Vot7 + 
clones  were  identical  (Table  1 A).  In  contrast,  all  four 
Vot8.1 + clones had different CDR3 sequences (not shown). 
All TCR/3 chains and 31 of the 33 ot chains were produc- 
tively rearranged. 
The results obtained with inverse PCR were confirmed 
with "family PCR" using primers specific for Vot33, Vfl5, 
and Vf113. Seven of eight Vot33 § clones  and five of eight 
Vf113 + family PCR-derived clones  had the same sequence 
as  six  of  six  Vc~33  +  and  five  of  eight  Vf113  +  inverse 
PCR-derived clones (Table 1, A and B, underlined sequences). 
In contrast, only two of the nine family PCR-derived Vfl5 + 
clones were identical to one of nine VB5 + clones  derived 
by inverse PCR (Table 1 B).  All Vfl13.1 + and one of the 
Vfl5.1 + sequences that shared identical CDR3 regions were 
rearranged to Jill.5  and Cfll (Table 1 B). 
We also analyzed PBMC from the same PM patient for 
TCR Vc~33, VflS, and Vf113 expression,  using TCR family 
PCR. None of the TCR sequences found in the muscle could 
be  detected  in  the  blood  (not  shown).  Furthermore,  by 
FACScan  |  analysis  (Becton Dickinson Immunocytometry 
Systems, Mountain View, CA), 2 %  of the CD4 + cells and 
1.3% of the CD8 + cells were V/313.1+; 2.8% of the CD4 + 
cells and 0.9%  of the CD8 + cells were Vfl5.1 + . The total 
proportion of CD4 § cells in the blood was 57.5%, and the 
proportion of CD8 + cells was 28.9%. These results are con- 
sistent with the assumption that Vot33.1 +,  VflS.1 +,  and 
Vfl13.1 § T cells accumulated or selectively expanded in the 
muscle. However, the blood sample was obtained later than 
the muscle biopsy after treatment with immunosuppressive 
drugs. Therefore, the possibility that the difference in TCR 
expression between blood and muscle was related to therapy 
cannot be excluded. 
It is tempting to directly relate  the clonal expansion of 
T cells to the pathogenesis (reviewed in reference 17). How- 
ever, clonal populations of CD8 § T  cells were observed  in 
the blood of normal elderly human subjects and mice (18-20). 
As pointed out by Posnett et al.  (18), the presence  of en- Table  1.  Sequence Analysis of TCR Expression in PM Lesions 
(A)  TCR Vo~ sequences (patient  1) 
Va33  N  Jc~  f* 
Inverse PCR 
33.1  LGGSGTY*  17.10  6/6 
Family PCR 
33.1  LGGSGTY*  17.10  7/8 
33.1  LGRETSYD  13.3  1/8 
(B) TCR V~ sequences (patient  1) 


















I GQGM  1.1  1  2/9  13.1 
GSGG  1.5  1  2/9  13.1 
LAGQP  1.1  1  1/9  13.1 
RGQGFG  1.6  1  1/9  13.4 
SGQGPPHG~  2.7  2  1/9 
LGNSGWV  1.1  1  1/9 
EGL  1.2  1  1/9 
Family PCR 
RGQGGG  2.5  2  2/9  13.1 
SGQGPPHG*  2.7  2  2/9  13.1 
LGQGPE  1.2  1  1/9  13.1 
NGQGL  1.2  1  1/9  13.2 
LGDRGQD  1.2  1  1/9 
SWTGEGTDT  2.7  2  1/9 
GLAGGP  2.1  2  1/9 
GVRGGY*  1.5  1  5/8 
YSGQGNP  1.1  1  1/8 
YSPQGW  1.2  1  1/8 
LQGSPR  1.1  1  1/8 
GVRGGY#  1.5  1  5/8 
RPDRGRA  1.4  1  1/8 
YEAGPD  2.7  2  1/8 
YSGAESW  1.5  1  1/8 
(C)  TCR V/3 sequences (patient 3) 
V/~3  N-D~-N  J~  C~  f* 
Family PCR 
3  FRGGVH  2.7  2  9/15 
3  LLASGSLGY  2.7  2  2/15 
3  LRTDA  1.4  1  2/15 
3  TRVGV  1.1  1  1/15 
3  LLASG I T  2.3  2  1/15 
*f, Frequency (number of positive clones divided by total number of clones). 
* Underlined sequences were observed by inverse and family PCR. 
larged clonal CD8 + T  cell populations in normal individ- 
uals should be considered in the interpretation of clonal T 
cell populations in disease  states.  Hence, evidence obtained 
by PCR alone for the presence of a clone of T  cells at the 
site of an immune response is insufficient to link the T cells 
to the pathogenesis of the disease (18). To learn whether the 
donaUy expanded TCR that we observed by PCR are pathoge- 
netically relevant, we studied muscle sections from the same 
patient by immunohistochemistry. 
In PM, two major populations of CD8 + T  cells can be 
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Inflammatory  T  Cells (Patient  I) 
(A) T  cells in  muscle  lesions 
CD8/V/~13.1  CD8/VB5.1 
Lesion  Lesion 
no.  +/-  +/+  -/+  no.  +/-  +/+  -/+ 
1  53  20  4  7  27  3  0 
2  21  10  0  8  28  11  2 
3  15  10  0  9  30  5  0 
4  12  13  1  10  39  4  0 
5  31  12  0  11  28  8  0 
6  23  7  1  12  45  6  0 
155  72  6  ~  197  37  2 
Figure  1.  Localization of CD8 and TCR. V3 elements by double-fluores- 
cence immunohistochemistry in three PM patients (A-C,  patient 1; D, 
patient 2; E, patient 3).  (.4) Colocalization of CD8  (green, FITC) and 
V313.1 (red, Cy3), patient 1. CDS* V/313.1 -  T cells are shown in green, 
CD8 + V313.1 + T  cells in yellow, and CDS-  V/313.1  + T  cells in red. 
Two adjacent muscle fibers (white dots) are surrounded and invaded by T 
cells. Two examples of CD8 + V313.1 + T  cells are marked with white 
arrows.  The  fiber on  the right  is  invaded  by at least  three additional 
CD8 + V/313.1  + T cells. The fiber on the left is invaded by at least one 
additional T  cell that  stained  green,  indicating that  it  is  CD8 +  but 
V/~13.1-.  Note red (CD8- V313.1 +) cell at the top of the figure,  x250. 
(/3) Colocalization of CD8 (green, FITC) and V/~13.1 (red, Cy3), patient 
1. Two adjacent  muscle fibers are surrounded but not deeply invaded by 
T cells. The yellow cells are CD8 § VI~13.1  +. Note heterogeneity of the 
infiltrate,  x125.  (C) Colocalization of CD8 (green, FITC) and V/~5.1 (red, 
Cy3) in patient 1. A small number of labeled (yellow or red) V~85.1  + cells 
are present among a majority of green (CD8 + V/35.1-) cells,  x125.  (D) 
Colocalization  of CD8 (green, FITC) and TCR V/~5.1 (red, Cy3) in muscle 
of patient 2. Double-positive cells appear yellow. Two muscle fibers are 
invaded by CD8 + V/35.1-  (green) T cells (arrows). The upper fiber (dot) 
is only superficially  invaded, x 250. (E) Colocalization of CD8 (green,  HTC) 
and TCR VB3 (red, Cy3) in the muscle of patient 3. Note cluster of CD8, 
TCR-V/~3 double-positive (yellow) T cells that invade a muscle fiber (dot). 
The majority of noninvasive (interstitial)  T cells are V/33-  (green). ￿ 
distinguished morphologically:  (a) autoinvasive T  cells that 
penetrate into muscle fibers; and (b) noninvasive T  cells that 
are located in interstitial areas (1-3).  We screened autoinva- 
sive and noninvasive T  cells for TCR  expression. Using mAbs 
specific for V313.1,  V35.1,  or CD8 and double-fluorescence 
immunohistochemistry,  we identified T  cells with  the pre- 
dicted TCR  V3  proteins in situ (Fig.  1, A-C)  and counted 
the cells expressing different phenotypes  in  12  focal inflam- 
matory  lesions  (Table  2).  Within  the  total  population  of 
CD8 +  T  cells, 32%  were V313.1 +  and  16%  were V~5.1 + 
(Table 2).  In contrast,  in the  subpopulation  of autoinvasive 
CD8 +  T  cells, ~60%  were V313.1 +  and 10%  were V35.1 + 
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(B)  Autoinvasive T  cells in  muscle fibers 
CD8/VB13.1  CD8/VB5.1 
Lesion  Lesion 
no.  +/-  +/+  -/+  no.  +/-  +/+  -/+ 
1  0  0  0  7  0  1  0 
2  2  2  0  8  1  0  0 
3  1  2  0  9  2  0  0 
4  1  2  0  10  6  0  0 
5  3  6  0  11  5  1  0 
6  2  0  0  12  5  0  0 
9  12  0  ~  19  2  0 
Six focal  inflammatory lesions  (1-6)  were analyzed by paired immu- 
nofluorescence for CD8 and V/313.1 (left columns),  and six lesions (7-12) 
for CD8 and V35.1  (right columns). Three different  phenotypes were 
distinguished:  CD8 +  V/3 -  ( + / -  ), CD8 +  Vl3 + ( + / + ), and CD8- V/3 + 
(-/+  ).  (A)  Numbers  of all cells  stained with  one  or  both  mAbs. 
72/(155+72)  =  32%  of  the  CD8 +  cells  were  V/313.1+  and 
37/(197 + 37)  =  16%  were V/35.1 +. (/3) Numbers of autoinvasive  cells 
stained with one or both mAbs. 60%  [12/(9 + 12)] of the autoinvasive 
CD8+  T  cells were V1313.1 + and  10%  [2/(19+2)]  were V135.1 +. 
(Table 2).  These  immunohistochemical  results  confirm  the 
presence  of Vt313.1 +  and  VB5.1 +  T  cells in the inflamma- 
tory  lesions,  and  they  indicate  that  the  clonally  expanded 
V1313.1 + CD8 + T  cells preferentially invaded muscle fibers. 
Using a series of different anti-TCR V3 mAbs (see Materials 
and Methods) for immunohistochemical  screening of muscle 
biopsy sections,  we identified two  additional patients  who 
showed  a  striking  accumulation  of CD8 +  T  cells staining 
for a particular VI3 element. In patient 2, 50%  of the T  cells 
were  V/35.1 +.  As  in  patient  1,  the  V/35.1 +  T  cells  were 
mainly located in  interstitial areas  (Fig.  1 D).  However,  in 
contrast  to patient  1,  the  autoinvasive T  cells could not  be 
stained with  anti-VBS.1,  anti-V1313.1,  or  any  other  of the 
available anti-TCR mAbs (not shown).  No RNA  was avail- able for TCR sequence analysis in patient 2, so that we could 
not determine the extent of clonal diversity of the interstitial 
V35.1 + or autoinvasive V35.1-  T  cells. 
In another patient, patient 3, 50% of all T cells and >75% 
of the autoinvasive T cells stained with an mAb against VB3 
(Fig. 1 E). Using a V33-specific primer, we amplified,  done& 
and  sequenced  15 V33 + cDNA clones from this patient's 
muscle. Nine clones (60%) had identical sequences (Table 1 
C). Of the remaining six clones, two pairs of sequences were 
also identical (Table 1 C). Thus, the results in patients 2 and 
3 confirm the findings in patient 1, demonstrating an accumu- 
lation of V3 + CD8 + T  cells, differential TCR usage by au- 
toinvasive and noninvasive (interstitial) T cells, and clonal ex- 
pansion  of autoinvasive T  cells. 
Previous studies of the TCK repertoire in PM did not com- 
bine sequence with histological analysis of TCR V3 expres- 
sion (21-23).  Using family PCR analysis  of needle biopsy 
specimens, one study (21) found preferential usage of Vctl, 
Voe5, V31, and V315, but no evidence for clonal expansion. 
By contrast, another report (22) described increased frequency 
of TCK Vet1 and VB6 and a high degree of donality in the 
V36 TCR family. The findings of preferential  TCR V  re- 
gion usage (21,  22) and clonality  (22)  are consistent with 
our results.  The differences in TCR usage observed in the 
different studies could relate to differences between patients 
(e.g.,  different HLA types). 
The approach we have taken to study the TCR repertoire 
in PM differs in two major aspects from the earlier studies 
(21, 22, 23). First, we combined two independent PCR tech- 
niques, inverse and family PCR. Inverse PCK is not biased 
by the selection of V region-specific primers (9), and the com- 
bination of two PCR techniques helps to minimize artifacts. 
Second,  we  combined  PCR  analysis  with  the  immuno- 
histochemical localization of T cells. This approach allowed 
us to study the heterogeneity and topology of TCR usage 
in individual lesions. 
We are aware that our data do not formally prove that the 
autoinvasive  CD8 § T cells actually destroy the muscle fibers. 
However, together with previous morphological (1-3,  24) 
and functional  (25) observations, the results are consistent 
with the following mechanism of muscle fiber injury: some 
muscle fibers,  which express MHC class I and MHC class 
I-associated auto-Ag(s)  (1-3),  are surrounded by CD8 + T 
cells. Some of the T cells traverse the basal lamina of the muscle 
fiber, contact the muscle fiber surface,  and migrate towards 
the center of the muscle fiber (1-3,  24). As shown by im- 
munoelectronmicroscopy, the autoinvasive T cells extend spike- 
like processes into the surrounding cytoplasm of the muscle 
fiber (24).  Eventually,  the autoinvasive CD8 + T  cells may 
literally "honeycomb" the muscle fiber (24).  Whether  the 
muscle fiber degenerates by apoptosis or necrosis has not been 
established (1-3,  24). 
In conclusion, our analysis demonstrates that the TCR V3 
repertoire expressed in the muscle of PM patients is highly 
restricted and that different V3 elements may predominate 
in different patients.  Furthermore,  we found that there is a 
dissociation between the TCR usage of autoinvasive and nonin- 
vasive CD8 + T  cells,  and that  the autoinvasive T  cells are 
clonally  expanded.  We  hypothesize  that  the  autoinvasive 
CD8 + T  cells are specific for the yet unknown auto-Ag(s). 
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